Pediatrix Medical Group, Inc.

Total Valuation

Pediatrix Medical Group, Inc. carries a market capitalization of 1.78B, placing it among publicly traded companies globally. Its enterprise value stands at 2.09B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

Pediatrix Medical Group, Inc. currently has 82.06M shares outstanding.

Valuation Ratios

Pediatrix Medical Group, Inc. trades at a trailing price-to-earnings ratio of 10.24. The price-to-sales ratio is 0.92, and the price-to-book ratio stands at -33.82.

Enterprise Valuation

On an enterprise value basis, Pediatrix Medical Group, Inc. trades at an EV/EBITDA multiple of 7.97 and an EV/FCF ratio of 6.79. The EV/Sales ratio of 1.08 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 8.73 provides insight into valuation relative to core operating earnings.

Financial Position

Pediatrix Medical Group, Inc. maintains a current ratio of 1.33, meaning it holds 1.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 71.67, indicating elevated leverage, while an interest coverage ratio of 7.46 demonstrates adequate ability to service its debt obligations.

Financial Efficiency

Taxes

Over the trailing twelve months, Pediatrix Medical Group, Inc. has paid 52.96M in income taxes, reflecting an effective tax rate of 23.31.

Stock Price Statistics

Pediatrix Medical Group, Inc.'s stock has gained approximately 56.73913% over the past 52 weeks. The 50-day moving average sits at 22.12, while the 200-day moving average is 20.36.

Income Statement

Over the trailing twelve months, Pediatrix Medical Group, Inc. generated 1.93B in revenue and converted that into 174.22M in net income, yielding earnings per share of 2.06. EBITDA reached 261.57M, while operating income came in at 238.96M.

Balance Sheet

Pediatrix Medical Group, Inc. holds 328.97M in cash and equivalents against 629.72M in total debt, resulting in a net debt position of 384.99M. Total book value stands at -52.76M, with working capital of 144.40M providing operational flexibility.

Cash Flow

Pediatrix Medical Group, Inc. produced 258.71M in operating cash flow over the past twelve months. After subtracting -21.39M in capital expenditures, free cash flow totaled 237.32M - equivalent to 2.84 per share.

Margins

Pediatrix Medical Group, Inc. operates with a gross margin of 26.09, reflecting its pricing power and cost economics. The operating margin of 12.37 and net profit margin of 9.02 provide insight into operational efficiency.

Dividends & Yields

Stock Splits

Pediatrix Medical Group, Inc.'s most recent stock split took place on December 20, 2013 with a 1:2 split ratio.

Scores

Pediatrix Medical Group, Inc. posts an Altman Z-Score of 4.48, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.